West Pharmaceutical Services Inc (WST)

Total asset turnover

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Revenue (ttm) US$ in thousands 2,931,600 2,918,300 2,862,000 2,884,600 2,888,000 2,911,600 2,929,000 2,882,500 2,833,200 2,681,100 2,521,700 2,320,600 2,141,400 2,030,200 1,941,400 1,887,900 1,839,900 1,791,800 1,767,400 1,745,200
Total assets US$ in thousands 3,829,500 3,754,700 3,669,600 3,723,600 3,616,800 3,316,800 3,361,700 3,294,700 3,313,800 3,142,600 2,933,500 2,739,700 2,793,800 2,582,800 2,392,300 2,246,500 2,341,400 2,174,000 2,123,200 2,036,200
Total asset turnover 0.77 0.78 0.78 0.77 0.80 0.88 0.87 0.87 0.85 0.85 0.86 0.85 0.77 0.79 0.81 0.84 0.79 0.82 0.83 0.86

December 31, 2023 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $2,931,600K ÷ $3,829,500K
= 0.77

The total asset turnover of West Pharmaceutical Services, Inc. has been relatively stable over the past eight quarters, ranging from 0.77 to 0.88. This ratio measures the efficiency with which the company generates revenue from its total assets. A total asset turnover of less than 1 indicates that the company is not generating as much revenue per dollar of assets, suggesting a lower efficiency in asset utilization.

West Pharmaceutical Services, Inc. has maintained a total asset turnover slightly below 1, indicating that the company may have room for improvement in utilizing its assets to generate revenue. It is important for the company to analyze and potentially optimize its asset management strategies to improve this ratio and enhance its overall operational efficiency.


Peer comparison

Dec 31, 2023

Company name
Symbol
Total asset turnover
West Pharmaceutical Services Inc
WST
0.77
Carlisle Companies Incorporated
CSL
0.69